Cardiff Oncology (CRDF) Earnings Date, Estimates & Call Transcripts

$3.63
-0.11 (-2.94%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(Feb. 29)
-$0.21 Beat By $0.05
Consensus EPS
(Feb. 29)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data

CRDF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRDF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cardiff Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.30)($0.23)($0.27)
Q2 20242($0.31)($0.24)($0.28)
Q3 20242($0.33)($0.25)($0.29)
Q4 20242($0.34)($0.26)($0.30)
FY 20248($1.28)($0.98)($1.13)
Q1 20251($0.28)($0.28)($0.28)
Q2 20251($0.27)($0.27)($0.27)
Q3 20251($0.31)($0.31)($0.31)
Q4 20251($0.31)($0.31)($0.31)
FY 20254($1.17)($1.17)($1.17)

CRDF Earnings Date and Information

Cardiff Oncology last released its quarterly earnings results on February 29th, 2024. The reported ($0.21) earnings per share for the quarter, topping analysts' consensus estimates of ($0.26) by $0.05. The firm earned $0.16 million during the quarter, compared to analyst estimates of $0.08 million. Cardiff Oncology has generated ($0.90) earnings per share over the last year (($0.90) diluted earnings per share). Earnings for Cardiff Oncology are expected to decrease in the coming year, from ($0.98) to ($1.06) per share. Cardiff Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Cardiff Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
Estimated)
------- 
2/29/2024Q4 2023($0.26)($0.21)+$0.05($0.21)$0.08 million$0.16 million
11/2/2023Q3 2023($0.29)($0.22)+$0.07($0.22)$0.08 million$0.14 million
8/9/2023Q2 2023($0.27)($0.25)+$0.02($0.25)$0.08 million$0.11 million
5/4/2023Q1 2023($0.23)($0.25)($0.02)($0.25)$0.08 million$0.08 million
3/2/2023Q4 2022($0.25)($0.20)+$0.05($0.20)$0.08 million$0.13 million
11/3/2022Q3 2022($0.27)($0.20)+$0.07($0.20)$0.08 million$0.09 million
8/4/2022Q2 2022($0.25)($0.24)+$0.01($0.24)$0.08 million$0.09 million
5/5/2022Q1 2022($0.23)($0.25)($0.02)($0.25)$0.08 million$0.07 million
2/24/2022Q4 2021($0.17)($0.23)($0.06)($0.23)$0.07 million$0.13 million    
11/4/2021Q3 2021($0.17)($0.17)-($0.17)$0.06 million$0.09 million
8/5/2021Q2 2021($0.15)($0.17)($0.02)($0.17)$0.07 million$0.07 million

Cardiff Oncology Earnings - Frequently Asked Questions

When is Cardiff Oncology's earnings date?

Cardiff Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on CRDF's earnings history.

Did Cardiff Oncology beat their earnings estimates last quarter?

In the previous quarter, Cardiff Oncology (NASDAQ:CRDF) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.05. Learn more on analysts' earnings estimate vs. CRDF's actual earnings.

How much revenue does Cardiff Oncology generate each year?

Cardiff Oncology (NASDAQ:CRDF) has a recorded annual revenue of $490,000.00.

How much profit does Cardiff Oncology generate each year?

Cardiff Oncology (NASDAQ:CRDF) has a recorded net income of -$41.44 million. CRDF has generated -$0.90 earnings per share over the last four quarters.

What is Cardiff Oncology's EPS forecast for next year?

Cardiff Oncology's earnings are expected to decrease from ($0.98) per share to ($1.06) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CRDF) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners